Cancer Immunotherapy Employing an Innovative Strategy to Enhance CD4+ T Cell Help in the Tumor Microenvironment

Development of CpG-Oligodeoxynucleotides for Effective Activation of Rabbit TLR9 Mediated Immune Responses

(2014) Tsung-Hsien Chuang et al.   PLoS One

Chemotherapy Acts as an Adjuvant to Convert the Tumor Microenvironment into a Highly Permissive State for Vaccination-Induced Antitumor Immunity

(2013) T. H. Kang et al.   CANCER RESEARCH

Enhanced Cancer Radiotherapy through Immunosuppressive Stromal Cell Destruction in Tumors

(2013) Chao-Yi Wu et al.   CLINICAL CANCER RESEARCH

Recent progress concerning CpG DNA and its use as a vaccine adjuvant

(2013) Hidekazu Shirota et al.   Expert Review of Vaccines

Control of spontaneous ovarian tumors by CD8+ T cells through NKG2D-targeted delivery of antigenic peptide

(2013) Tae Kang et al.   Cell and Bioscience

Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine

(2012) Shiwen Peng et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Clinical Evaluation of Safety and Immunogenicity of PADRE-Cytomegalovirus (CMV) and Tetanus-CMV Fusion Peptide Vaccines With or Without PF03512676 Adjuvant

(2012) Corinna La Rosa et al.   JOURNAL OF INFECTIOUS DISEASES

Targeted Coating With Antigenic Peptide Renders Tumor Cells Susceptible to CD8+ T Cell-mediated Killing

(2012) Tae Heung Kang et al.   MOLECULAR THERAPY

Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL

(2011) P. Sinha et al.   BLOOD

CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice

(2011) C. Zoglmeier et al.   CLINICAL CANCER RESEARCH

Optimized combination therapy using bortezomib, TRAIL and TLR agonists in established breast tumors

(2010) Sujin Lee et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer

(2010) A Wu et al.   GENE THERAPY

Role of IL-2 secreted by PADRE-specific CD4+ T cells in enhancing E7-specific CD8+ T-cell immune responses

(2008) D Kim et al.   GENE THERAPY